DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis—Challenges and Critical Points in Implementation into Clinical Routine

The novel compound 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-ZOL (DOTA-conjugated zoledronic acid) is a promising candidate for the diagnosis and therapy of bone metastasis. The combination of the published methodology for this bisphosphonate with pharmaceutical and regulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Meisenheimer, Michael, Kürpig, Stefan, Essler, Markus, Eppard, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412164/
https://www.ncbi.nlm.nih.gov/pubmed/32629930
http://dx.doi.org/10.3390/molecules25132988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7412164/
https://www.ncbi.nlm.nih.gov/pubmed/32629930
http://dx.doi.org/10.3390/molecules25132988

Ejemplares similares